ACURX PHARMACEUTICALS INC (ACXP:NASDAQ)

$1.99 0.05 (2.5773%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 71

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ACURX PHARMACEUTICALS INC (ACXP:NASDAQ) News Sources

Acurx Pharmaceuticals, Inc. Announces up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

16-04-2026

yahoo.com

Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

16-04-2026

yahoo.com

New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics (NASDAQ:VVOS)

18-04-2026

yahoo.com

Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update

20-04-2026

yahoo.com

Acurx Pharmaceuticals, Inc. To Present at The Market Movers Investor Summit

27-04-2026

yahoo.com

Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase

29-04-2026

yahoo.com

Acurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors' Microbiome Evaluation at ESCMID Global 2026

04-05-2026

yahoo.com

Acurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update

12-05-2026

yahoo.com

Acurx Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary

12-05-2026

moby.co

Acurx Pharmaceuticals (NASDAQ: ACXP) Highlights FDA's New CDI Guidance That Could Accelerate Approval Path for Ibezapolstat

19-05-2026

yahoo.com

ACURX PHARMACEUTICALS INC (ACXP:NASDAQ) Sentiment Trend

0 25 50 75 100 86 33 62 85 85 92 60 87 29 89 16-04-2026 18-04-2026 20-04-2026 27-04-2026 29-04-2026 04-05-2026 12-05-2026 19-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ACURX PHARMACEUTICALS INC (ACXP:NASDAQ) FAQs

toggle

What is the current price of ACURX PHARMACEUTICALS INC (ACXP:NASDAQ)?

The current price of ACURX PHARMACEUTICALS INC (ACXP:NASDAQ) is $1.99.


toggle

ACURX PHARMACEUTICALS INC (ACXP:NASDAQ) absolute price change since previous trading day?

The absolute price change of ACURX PHARMACEUTICALS INC (ACXP:NASDAQ) since the previous trading day is $0.05.


toggle

ACURX PHARMACEUTICALS INC (ACXP:NASDAQ) percentage price change since previous trading day?

The percentage price change of ACURX PHARMACEUTICALS INC (ACXP:NASDAQ) since the previous trading day is 2.5773%.


toggle

What is the most recent average sentiment score for ACURX PHARMACEUTICALS INC (ACXP:NASDAQ)?

The most recent average sentiment score for ACURX PHARMACEUTICALS INC (ACXP:NASDAQ) is 71 out of 100.


toggle

What is the most recent average sentiment for ACURX PHARMACEUTICALS INC (ACXP:NASDAQ)?

The most recent sentiment for ACURX PHARMACEUTICALS INC (ACXP:NASDAQ) is .


SEC-8K** Filing Available For ACURX PHARMACEUTICALS INC (ACXP:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.